Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
INFLEX: SCFAs in Endotoxemia-Induced Inflammation and Core Executive Functioning
NCT07713641Recruiting
- Sponsor
- UZ Leuven
- Start
- Oct 2025
- Primary completion
- Mar 2027
- Countries
- 1
01
Overview
Randomised, triple-blind trial in endotoxemia and inflammation (2 arms), sponsored by UZ Leuven. Primary endpoint: Serum interleukin-6 response at 6 hours. Started Oct 2025; status: recruiting.
02
Conditions
endotoxemiainflammation
Beyond the preview
Go deeper on NCT07713641.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07713641.